IMAC Holdings to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
IMAC Holdings, Inc. (Nasdaq: IMAC) announces that CEO Jeffrey Ervin will present at the H.C. Wainwright Bioconnect 2021 Virtual Conference from January 11-14, 2021. The on-demand presentation will be available starting at 6:00 AM ET on January 11. IMAC specializes in regenerative rehabilitation orthopedic treatments, aiming to provide care without surgery or opioids. Founded in 2015, IMAC operates 15 outpatient clinics focusing on sports and orthopedic injuries, partnering with former professional athletes to enhance its service offerings.
- None.
- None.
BRENTWOOD, Tenn., Jan. 05, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces its CEO Jeffrey Ervin will present at the H.C. Wainwright Bioconnect 2021 Virtual Conference taking place January 11-14, 2021.
The presentation will be available for on-demand listening beginning at 6:00 AM Eastern Time on Monday, January 11, 2021, through the close of business January 14, 2021. For those interested in viewing Mr. Ervin’s presentation, registration can be accessed here.
About IMAC Holdings, Inc.
IMAC was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages 15 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening six Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, as well as Mike Ditka IMAC Regeneration Centers and a Tony Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids. More information about IMAC Holdings, Inc. is available at www.imacregeneration.com.
# # #
Safe Harbor Statement
This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.
IMAC Press Contact:
Laura Fristoe
Investor Relations:
Bret Shapiro
(516) 222-2560
FAQ
When will IMAC Holdings present at the H.C. Wainwright Bioconnect 2021 Virtual Conference?
What time will the IMAC presentation be available for on-demand listening?
What does IMAC Holdings specialize in?
How many outpatient clinics does IMAC operate?
What is the stock symbol for IMAC Holdings?
